| P50 | author | Amal Rayan | Q88802351 |
| P2093 | author name string | Ahmed Soliman | |
| | Asmaa M Zahran | |
| | Ahmed M Ashmawy | |
| | Alia M Attia | |
| | Azza Elkady | |
| | Helal F Hetta | |
| | Hussein Fakhry | |
| P2860 | cites work | Global cancer statistics | Q22241238 |
| | CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells | Q24317839 |
| | Prospective identification of tumorigenic breast cancer cells | Q24683474 |
| | CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis | Q26827628 |
| | CD133: molecule of the moment | Q28260425 |
| | Cancer stem cells in solid tumours: accumulating evidence and unresolved questions | Q28293535 |
| | CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma | Q28302505 |
| | Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy | Q33344524 |
| | Detection and characterization of CD133+ cancer stem cells in human solid tumours | Q33378520 |
| | The therapeutic promise of the cancer stem cell concept | Q33559711 |
| | More than markers: biological significance of cancer stem cell-defining molecules | Q33661278 |
| | Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker | Q34203737 |
| | Evolution of the cancer stem cell model | Q34408981 |
| | Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial | Q34607843 |
| | Colorectal cancer in Egypt | Q34916510 |
| | CD24 and human carcinoma: tumor biological aspects | Q36409389 |
| | Mechanisms of chemoresistance in cancer stem cells | Q36591484 |
| | CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer | Q36615659 |
| | CD133 expression is an independent prognostic marker for low survival in colorectal cancer | Q36944002 |
| | Clinical and biological significance of aneuploidy in human tumours | Q37184664 |
| | Is lymph node count an ideal quality indicator for cancer care? | Q37331856 |
| | CD133 expression associated with poor prognosis in ovarian cancer | Q37373712 |
| | Cancer stem cells and radiotherapy. | Q37453248 |
| | Tumour-initiating cells: challenges and opportunities for anticancer drug discovery | Q37606286 |
| | Regulation of self-renewal in normal and cancer stem cells. | Q38030660 |
| | Prognostic value of cancer stem cell marker CD133 expression in non-small cell lung cancer: a systematic review | Q38162444 |
| | Stem cells in gastrointestinal cancers: The road less travelled | Q38271602 |
| | Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancer | Q39365698 |
| | The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients | Q39442334 |
| | Characterization of a subpopulation of colon cancer cells with stem cell-like properties | Q39906634 |
| | Biological and genetic characteristics of tumor-initiating cells in colon cancer | Q40068640 |
| | Flow cytometry in clinical cancer research | Q40153214 |
| | CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis | Q40345092 |
| | DNA aneuploidy in colorectal adenomas | Q41142039 |
| | Cancer stem cells as 'units of selection'. | Q42108136 |
| | Molecular markers in circulating tumour cells from metastatic colorectal cancer patients | Q42914366 |
| | Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer. | Q50975038 |
| | Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. | Q53444980 |
| | Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study. | Q53457814 |
| | Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases. | Q53634556 |
| | Cancer stem cells in radiation resistance. | Q55467719 |
| | CD44 is of Functional Importance for Colorectal Cancer Stem Cells | Q58022858 |
| | Colon cancer stem cells | Q61788251 |
| | Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins | Q71657938 |
| | Cancer stem cells | Q80312237 |
| | Cell cycle analysis of the CD133(+) and CD133(-) cells isolated from human colorectal cancer | Q85510527 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neoplastic stem cells | Q1638475 |
| | colorectal cancer | Q188874 |
| | Cancer stem cells | Q58043055 |
| P304 | page(s) | 1237-1248 | |
| P577 | publication date | 2019-02-07 | |
| P1433 | published in | Cancer Management and Research | Q5031417 |
| P1476 | title | Pretreatment detection of circulating and tissue CD133+ CD44+ cancer stem cells as a prognostic factor affecting the outcomes in Egyptian patients with colorectal cancer | |
| P478 | volume | 11 | |